Monte Rosa Therapeutics
GLUE
#7806
Rank
$0.24 B
Marketcap
$3.95
Share price
1.54%
Change (1 day)
-44.13%
Change (1 year)

Earnings for Monte Rosa Therapeutics (GLUE)

Earnings in 2024 (TTM): -$70.13 Million USD

According to Monte Rosa Therapeutics's latest financial reports the company's current earnings are $75.62 Million USD. , an increase over its 2023 earnings that were of -$0.14 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Monte Rosa Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 -$70.13 Million-48.06%
2023 -$0.14 Billion24.43%
2022 -$0.11 Billion46.71%
2021 -$73.96 Million106.13%
2020 -$35.88 Million